Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Diabetic Macular Edema
Interventions
DRUG

Bevacizumab

Bevacizumab is an off-label but cheaper treatment for diabetic macular edema.

DRUG

Ranibizumab

Ranibizumab is a vascular endothelial growth factor inhibitor designed for ocular use

Trial Locations (1)

K7L 5G2

Hotel Dieu Hospital, Kingston

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Queen's University

OTHER

NCT01661946 - Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye | Biotech Hunter | Biotech Hunter